Gambaran Penggunaan Obat Infeksi Saluran Pernapasan Akut (ISPA) pada Pasien Anak di Klinik X Kabupaten Tangerang Periode Januari-Maret 2025

Authors

  • Wafa Wafa Universitas Pembangunan Nasional Veteran Jakarta
  • Mochammad Hasan Sekolah Tinggi Ilmu Kesehatan Widya Dharma Husada Tangerang

DOI:

https://doi.org/10.59841/an-najat.v3i3.3279

Keywords:

Acute Respiratory Infection (ARI), Children, Drug Utilization, Medical Records, Supportive Therapy

Abstract

Acute Respiratory Tract Infection (ARI) remains one of the most common infectious diseases and a major public health concern in Indonesia. ARI is an infection that affects both the upper and lower respiratory tract, with symptoms ranging from mild to severe. This disease can occur across all age groups; however, data from the 2018 Basic Health Research (Riskesdas) revealed that the highest prevalence was found in children aged 1–4 years, accounting for 13.7%. The high incidence among young children highlights the importance of evaluating drug utilization patterns, particularly in relation to therapy choices and adherence to medical service standards. This study aimed to describe the pattern of drug use in pediatric patients diagnosed with ARI at Clinic X, Tangerang Regency. The variables observed included age group, sex, type of therapy, drug class, specific drugs prescribed, and dosage forms. This research employed a descriptive design with a retrospective approach, using data obtained from pediatric medical records. Samples were selected through probability sampling with a stratified random sampling technique, resulting in 185 eligible medical records. The findings indicated that pediatric ARI patients were predominantly within the age range of 0–5 years (54.6%), with a slightly higher proportion of males (51.9%). In terms of therapy, most patients received supportive treatment (71.9%). Regarding drug classification, antihistamines were the most frequently used (20.9%), with cetirizine being the most prescribed drug (20.8%). Powder formulations were the most common dosage form administered (48.8%), which may reflect the convenience of use in pediatric patients. Based on these results, it is recommended that the completeness of patient medical records be improved to ensure more accurate evaluation and clinical decision-making. Furthermore, strengthening adherence to medical service standards in the management of pediatric ARI is essential to ensure rational, effective, and safe drug therapy.

References

Ahmad, A., & Khan, M. (2019). Parents' knowledge and practices regarding acute respiratory infections in children. BMC Pediatrics, 19(1), 82. https://doi.org/10.1186/s12887-019-1444-5

Apriliani, R., & Cahyaningrum, E. (2022). Epidemiologi ISPA pada anak di negara berkembang. Jurnal Kesehatan Masyarakat, 18(2), 123–130. https://doi.org/10.24832/jkm.v18i2.12345

Chen, Y., Li, X., & Wang, Z. (2020). Antibiotic use in pediatric respiratory infections: A global perspective. Journal of Global Health, 10(2), 021103. https://doi.org/10.7189/jogh.10.021103

Endang, S., Mairanny, A., & Salsabilla, D. (2021). Faktor risiko ISPA pada anak di Indonesia. Jurnal Epidemiologi Indonesia, 5(1), 45–53.

Firza, M., Rahayu, N., & Putri, A. (2020). Gambaran klinis ISPA pada balita. Indonesian Journal of Pediatric Medicine, 12(3), 210–218.

Gupta, A., & Singh, R. (2021). Pediatric pharmacotherapy in respiratory infections. International Journal of Pediatrics, 2021, 6673129. https://doi.org/10.1155/2021/6673129

Kementerian Kesehatan Republik Indonesia. (2018). Riset Kesehatan Dasar 2018. Badan Penelitian dan Pengembangan Kesehatan.

Lee, J. H., & Park, S. H. (2021). Clinical management of pediatric acute respiratory infections. Pediatric Infection & Vaccine, 28(1), 1–10.

Li, Q., & Zhou, Y. (2022). Antihistamines in viral respiratory infections: Evidence and controversies. Frontiers in Pediatrics, 10, 923117. https://doi.org/10.3389/fped.2022.923117

Mega, S., Nurcahyo, H., & Ratih, S. (2020). Penggunaan obat ISPA pada anak di Puskesmas Bangun Galih. Pharmaceutical Sciences and Research, 7(2), 95–101.

Nguyen, T., & Tran, H. (2019). The burden of acute respiratory infections in Southeast Asia. Asian Pacific Journal of Tropical Medicine, 12(5), 225–232.

Niku, R., Fajar, S., & Yan, A. (2021). Perbedaan respons farmakoterapi antara anak dan dewasa pada penyakit infeksi. Jurnal Farmasi Klinik Indonesia, 10(1), 15–23.

Nur, R., & Dewi, H. (2020). Rasionalitas penggunaan obat pada pasien ISPA anak di Puskesmas Mataram. Jurnal Ilmu Kefarmasian Indonesia, 18(1), 67–74.

Nurul, M., Ressi, S., & Eka, K. (2017). Gambaran penggunaan antibiotik pada pasien ISPA anak. Jurnal Farmasi dan Klinik, 5(3), 89–95.

Patel, S., & Smith, J. (2020). Rational drug use in childhood respiratory infections. Pharmacy Practice, 18(3), 1882. https://doi.org/10.18549/PharmPract.2020.3.1882

Prasiwi, L., Hidayat, A., & Sari, P. (2021). Status gizi sebagai faktor risiko ISPA pada balita. Jurnal Gizi dan Kesehatan, 13(2), 112–119.

Santos, R., & Oliveira, M. (2020). Vitamin supplementation in respiratory infections among children. Nutrients, 12(8), 2405. https://doi.org/10.3390/nu12082405

Sharma, N., & Kumar, P. (2019). Antibiotic resistance trends in pediatric respiratory tract infections. Journal of Infection and Public Health, 12(6), 843–849. https://doi.org/10.1016/j.jiph.2019.05.012

Suarnianti, & Kadrianti, S. (2019). Pola penularan ISPA pada anak di lingkungan padat penduduk. Jurnal Kesehatan Lingkungan, 17(2), 78–85. https://doi.org/10.30998/lja.v2i01.3465

Wang, Y., & Chen, L. (2021). Clinical outcomes of bronchodilator use in pediatric ARI. Respiratory Medicine, 182, 106412. https://doi.org/10.1016/j.rmed.2021.106412

World Health Organization. (2020). Acute respiratory infections in children: Global epidemiology and prevention. WHO.

Wulandhani, D., & Purnamasari, R. (2019). Pengaruh kondisi rumah terhadap kejadian ISPA balita. Jurnal Kesehatan Masyarakat, 11(1), 23–31.

Yuliani, R. G., et al. (2019). Vitamin dan perannya dalam imunitas anak. Jurnal Gizi Klinik Indonesia, 15(2), 134–142.

Zhao, X., & Liu, J. (2022). Corticosteroid therapy in acute respiratory infections: Benefits and risks. Pediatric Pulmonology, 57(1), 45–53.

Zulfikar, M., & Sukriadi, T. (2021). Dampak asap rokok terhadap kejadian ISPA balita. Jurnal Kedokteran Respirasi, 9(1), 25–32.

Downloads

Published

2025-09-02

How to Cite

Wafa Wafa, & Mochammad Hasan. (2025). Gambaran Penggunaan Obat Infeksi Saluran Pernapasan Akut (ISPA) pada Pasien Anak di Klinik X Kabupaten Tangerang Periode Januari-Maret 2025. An-Najat, 3(3), 337–344. https://doi.org/10.59841/an-najat.v3i3.3279

Similar Articles

1 2 3 4 5 6 7 8 9 > >> 

You may also start an advanced similarity search for this article.